Filing Details

Accession Number:
0000014272-25-000133
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-08-05 17:58:58
Reporting Period:
2025-08-02
Filing Date:
2025-08-05
Accepted Time:
2025-08-05 17:58:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2070839 Wendy Bartie Short Bristol-Myers Squibb Company
Route 206 &Amp; Province Line Road
Princeton NJ 08543
Evp, Corporate Affairs No Yes No No
Transaction Summary
Sold: 378 shares Avg. Price: $44.23 Total Value: $16,718.94
Number of Shares After Transactions: 5,066 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Acquisiton 2025-08-02 738 $0.00 5,444 No 4 M Direct
Common Stock, $0.10 Par Value Disposition 2025-08-02 378 $44.23 5,066 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.10 Par Value Restricted Stock Units Disposition 2025-08-02 738 $0.00 738 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-08-02 No 4 M Direct
Footnotes
  1. These restricted stock units vest in four equal installments beginning on August 2, 2022.
  2. Shares withheld for payment of taxes upon vesting of award.
  3. Each restricted stock unit converts into one share of common stock upon vesting.